A spokeswoman for the German Health Ministry confirmed to Reuters earlier reports of US President Donald Trump's offer to a German company, whose teams are working on developing a potential vaccine for the novel coronavirus. CureVac focuses on the development of a mRNA-based coronavirus vaccine to protect people worldwide. We abstain from commenting on speculations and rejects allegations about offers for acquisition of our company or our technology. To our ...